Mitchell Revill
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Oncology 4
- Lung Cancer Research Studies 4
-
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Lorraine M. Mooney (1 shared paper)Mike A. Firth (1 shared paper)Claire M. Rooney (1 shared paper)Paul David Smith (1 shared paper)Susan E. Critchlow (1 shared paper)Paul D. Lyne (1 shared paper)Sanjay Pandey (1 shared paper)Filippos Michopoulos (1 shared paper)
- Journals
- Nature Cancer (1 paper)Science Translational Medicine (1 paper)Nature Communications (1 paper)Oncotarget (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Mitchell Revill
7 papers receiving 543 citations
Peers
Comparison fields: 5 of 51
- Oncology 236
- Cancer Research 125
- Molecular Biology 160
- Pulmonary and Respiratory Medicine 33
- Immunology 16
Countries citing papers authored by Mitchell Revill
This map shows the geographic impact of Mitchell Revill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Revill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Revill more than expected).
Fields of papers citing papers by Mitchell Revill
This network shows the impact of papers produced by Mitchell Revill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Revill. The network helps show where Mitchell Revill may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Revill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 157 | |
| 2 | 2020 | 140 | |
| 3 | 2017 | 134 | |
| 4 | 2020 | 65 | |
| 5 | 2021 | 22 | |
| 6 | 2013 | 21 | |
| 7 | 2025 | 8 |
About Mitchell Revill
Mitchell Revill is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Nuclear Energy and Engineering, having authored 7 papers that have together received 547 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), RNA Interference and Gene Delivery (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Protein Tyrosine Phosphatases (1 paper) and MRI in cancer diagnosis (1 paper). The work is most often cited by research in Oncology (236 citations), Cancer Research (125 citations), Molecular Biology (160 citations), Pulmonary and Respiratory Medicine (33 citations) and Immunology (16 citations). Mitchell Revill has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Lorraine M. Mooney, Mike A. Firth, Claire M. Rooney, Paul David Smith, Susan E. Critchlow, Paul D. Lyne, Sanjay Pandey, Filippos Michopoulos, Rebecca P.A. Ellston and Stephen A. Green. Their work appears in journals such as Nature Cancer, Science Translational Medicine, Nature Communications, Oncotarget and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.